Healthy Skepticism Library item: 8332

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Wechsler J.
Washington report: new year promises new initiatives, new FDA commissioner
Pharmaceutical Technology 1997 Jan; 21:16, 18, 20, 22, 24, 26

Abstract:

An emerging cooperative tone in Washington unlikely to encourage congressional approval of radical U.S. Food and Drug Administration (FDA) reform legislation is discussed, including how the departure of FDA commissioner David Kessler will also affect prospects for reform and continued internal efforts for changes in FDA policy and practice. Issues likely to be considered in the coming year are medical care reform, expansion of health care coverage to the uninsured, Prescription Drug User Fee Act negotiation, patent extensions and reform, and drug price controls.